Nikomed to Introduce the World's First 100% Recyclable Medical Lead Wire Solution at FIME 2019

Friday, May 24, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Nikomed USA Inc. ("Nikomed"), a leading provider of disposable cardiology and surgical products to the healthcare industry, will debut its patent-pending BioWire™ System at the Florida International Medical Expo (FIME 2019), June 26-28, at the Miami Beach Convention Centre, Booth #C68.

HATBORO, Pa., May 23, 2019 /PRNewswire-PRWeb/ -- The world's first non-metal disposable and universal lead wire system,

BioWire is a cost effective, ecologically friendly printed disposable lead wire. Unlike metal disposable leads, BioWire System is made using a printed conductive silver ink.

"We're justifiably excited about this product and its potential, and FIME is an ideal venue to introduce it," commented Steve Epstein, President of Nikomed. "Select groups of caregivers who have previewed BioWire have been enthusiastic and given it high praise."

BioWire provides significant advantages over traditional disposable leads. First and foremost is its recyclability. Many healthcare institutions using metal leads are confronted with the challenge of disposal, as the material cannot be recycled. Such is not the case with Biowire. Constructed with polyethylene terephthalate (PET) and a silver ink, it is designated as a recyclable material. Applicability is another advantage. BioWire easily adapts to most monitoring equipment and all ECG electrodes. Adding to its list of advantages, Biowire's ribbon-like design allows for writing or applying a label on the wiring itself for patient and test identification. Now in the final stages of development, Nikomed expects to begin filling orders in the last quarter of 2019.

"We are extremely selective of the products we introduce, and each one must satisfy three key criteria," Epstein explained. "First, they must represent a superior or more effective solution for the patient. Second, they must be easier for the practitioner to utilize or apply. Finally, they must make financial sense. With the BioWire, I can confidently say that all three criteria have been met."

In addition to the introduction of Biowire, Nikomed will be featuring several other new solutions at FIME this year. These include the Vivolight Vein Finder, Vistar Medical disposable blood pressure cuff & device, innovative MMA Mouthguard Airway, and MESI advanced Ankle-Brachial Index (ABI) testing solution that can be accomplished in 60 seconds.

Nikomed has an established history in the medical products field that dates back more than 30 years and across two generations of Epstein leadership. In 1982, Founder Don Epstein developed one of the first diagnostic tab electrodes, Signa Sensor. Epstein added, "We have a great legacy of introducing meaningful solutions to the industry, and together with my brother Neil (VP of Sales), maintain that pioneering spirit to this day."

Nikomed Welcomes Attending Media Representatives Media representatives are welcome to visit the Nikomed exhibit for a first-hand demonstration of the BioWire and other featured innovations. Nikomed's President, Steve Epstein and VP of Sales, Neil Epstein will both be present at FIME this year. To schedule an onsite interview, please contact: Ed Delia, Delia Associates (E: edelia@delianet.com) with the subject "FIME Interview" or call 908-534-9044.

About Nikomed USA. Founded in 1986, Nikomed USA is headquartered in Hatboro, Pennsylvania. As the only indirect ECG electrode supplier in the world, the company provides a full line of the highest quality equipment, devices and accessories to the healthcare industry, including Resting and Monitoring ECG Electrodes, Electro-Surgical Grounding Pads and Related Accessories through its extensive network of distribution partners.

For more information, please visit: http://www.nikomedusa.com.

For additional press information, please contact: Ed Delia Delia Associates edelia@delianet.com 908-534-9044

 

SOURCE Nikomed USA Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store